2012 annual financial data
Halozyme Therapeutics 2012 Operating margin
Halozyme Therapeutics 2012 operating margin with verified reported values.
Direct answer
Operating margin was -126.7%.
Operating income was -53,625,446 USD and net income was -53,552,002 USD.
Operating cash flow was -64,329,296 USD.
Get free Halozyme Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 42,325,226 USD
- Operating income
- -53,625,446 USD
- Net income
- -53,552,002 USD
- Operating cash flow
- -64,329,296 USD